Switching from initial first-line agents to other disease modifying therapies: an observational study - Archive ouverte HAL Access content directly
Journal Articles Multiple Sclerosis Journal Year : 2015

Switching from initial first-line agents to other disease modifying therapies: an observational study

Abstract

no abstract
Not file

Dates and versions

hal-01259386 , version 1 (20-01-2016)

Identifiers

  • HAL Id : hal-01259386 , version 1

Cite

Emmanuelle Le Page, Véronique Deburghgraeve, Anne Kerbrat, Gilles Edan. Switching from initial first-line agents to other disease modifying therapies: an observational study. Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.601--602. ⟨hal-01259386⟩
20 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More